PEOPLE first reported news of Dane’s passing, which comes 10 months after he revealed he had been diagnosed with the progressive and terminal neurodegenerative disease. Other outlets, including TMZ, ...

Dane announced his ALS diagnosis last April, and head been an open advocate for research and treatment until his death.

UK-based trial first to evaluate neflamapimod in ALS; first person with ALS expected to be dosed by end of 2026 Trial costs ...

A study is exploring why athletes, first responders, and other high performers face an increased risk of developing ALS.

Chief Secretary, Atal Dulloo, today chaired review meeting to assess the progress of the remaining works under the Jhelum ...

Minaurum Silver Inc. (TSXV: MGG) (OTCQX: MMRGF) ("Minaurum") is pleased to report results from the first holes of its Phase 2 ...

Meryllion Resources Corporation (CSE: MYR) ("Meryllion" or the "Company") is pleased to announce that drilling commenced on schedule earlier this week at its ionic adsorption clay (IAC) hosted rare ...

Neflamapimod endorsement based on targeted mechanism of action, demonstrated clinical activity in neurodegenerative diseases, and encouraging translational data in ALS-relevant neurotoxicity models UK ...

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with no cure and limited treatment options. One of the earliest signs of ALS is overactive brain signals known as ...

High-Grade Samples Returned in a New Previously Unsampled Area of Poverty Creek and Identifies Multiple Structural Trends ...

Glenstar Minerals Inc. (CSE: GSTR) (OTCQB: GSTRF) (FSE: VO20) ("Glenstar" or the "Company") announces that the Phase 2 drill program at the Company's Green Monster Project in Nevada has been completed ...

Join us for an inspiring, hope-filled evening of music raising funds for the ALS Society of BC and ALS Society of BC's PROJECT HOPE. The year’s event is dedicated to the memory and enduring spirit of ...